Drs Judith G. Hall and Julio Montaner have been selected for induction into the Canadian Medical Hall of Fame (along with four other doctors from across Canada) for their national and international contributions to patient care, health systems, education, and research.
Dr Judith G. Hall
|Dr Hall is a pediatrician and geneticist specializing in the genetic factors that affect children’s growth. With more than 325 publications, Dr Hall has been at the international forefront of genetics and pediatrics for more than 4 decades. Her particular interests include human congenital anomalies including neural tube defects, connective tissue disorders such as arthrogryposis and dwarfism, and disorders resulting in short stature. Data from her research are available in the Handbook of Physical Measurements. As head of pediatrics at UBC and BC Children’s Hospital, Dr Hall worked with physicians to develop guidelines for care of common disorders, and with lay groups to explain genetic disease that helped parents choose from among the care options available|
Dr Julio Montaner
|Dr Montaner led an international consortium of investigators to test the viability of a triple drug combination call-ed highly active antiretroviral therapy (HAART) to suppress HIV replication, thereby sending the disease into full and lasting remission. In 2000, the World Health Organization and the UNAIDS program adopted HAART as the global standard of therapy. Dr Montaner pioneered the notion of treatment as prevention (TasP), an expansion of HAART coverage, to decrease both the progression of HIV to AIDS and death and HIV transmission. He is the architect of the proposed UN 90-90-90 strategy aimed at ending the AIDS pandemic by 2030. His focus includes HAART access in hard-to-reach populations, including injection drug users, and the treatment of multiple-drug-resistant HIV infection. Dr Montaner is a professor of medicine at UBC, founding co-director of the Canadian HIV Trials Network, and director of the BC Centre for Excellence in HIV/AIDS at St. Paul’s Hospital.|
|The induction ceremony will be held on 23 April 2015 at the Metropolitan Entertainment Centre in Winnipeg, Manitoba.|
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org